Showing 1 - 9 results of 9 for search 'Miguel Angel López Ruz', query time: 0.04s
Refine Results
-
1
-
2
A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment. by Elena Pérez-Antón, Adriana Egui, M Carmen Thomas, Bartolomé Carrilero, Marina Simón, Miguel Ángel López-Ruz, Manuel Segovia, Manuel Carlos López
Published 2021-02-01
Article -
3
Assisted Reproductive Technology and Obstetric Outcome in Couples when The Male Partner Has A Chronic Viral Disease by Irene Molina, María Carmen del Gonzalvo, Ana Clavero, Miguel Ángel López-Ruz, Juan Mozas, Juan Pasquau, Antonio Sampedro, Luis Martínez, José Antonio Castilla
Published 2014-01-01
Article -
4
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV by Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, Leopoldo Muñoz-Medina, Sergio Sequera, Rosario Javier, Miguel Ángel López-Ruz, Svetlana Sadyrbaeva-Dolgova, Juan Pasquau
Published 2022-11-01
Article -
5
Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients by Juan Francisco Gutiérrez-Bautista, Alba Martinez-Chamorro, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, Pilar Jiménez, Per Anderson, Miguel Ángel López-Ruz, Miguel Ángel López-Nevot, Francisco Ruiz-Cabello
Published 2022-06-01
Article -
6
Antiretroviral therapy as a factor protective against anal dysplasia in HIV-infected males who have sex with males. by Carmen Hidalgo-Tenorio, Mar Rivero-Rodriguez, Concepción Gil-Anguita, Mercedes Lopez De Hierro, Pablo Palma, Jessica Ramírez-Taboada, Javier Esquivias, Miguel Angel López-Ruz, Rosario Javier-Martínez, Juan Pasquau-Liaño
Published 2014-01-01
Article -
7
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients by Juan Francisco Gutiérrez-Bautista, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, Miguel Ángel López-Ruz, Antonia María Martín-Casares, Alonso Fernández-Rubiales, Per Anderson, Federico Garrido, Francisco Ruiz-Cabello, Miguel Ángel López-Nevot
Published 2022-06-01
Article -
8
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks) by Carmen Hidalgo-Tenorio, Juan Pasquau, David Vinuesa, Sergio Ferra, Alberto Terrón, Isabel SanJoaquín, Antoni Payeras, Onofre Juan Martínez, Miguel Ángel López-Ruz, Mohamed Omar, Javier de la Torre-Lima, Ana López-Lirola, Jesús Palomares, José Ramón Blanco, Marta Montero, Coral García-Vallecillos
Published 2022-03-01
Article -
9
High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. by Miguel Ángel López Zúñiga, Aida Moreno-Moral, Ana Ocaña-Granados, Francisco Andrés Padilla-Moreno, Alba María Castillo-Fernández, Dionisio Guillamón-Fernández, Carolina Ramírez-Sánchez, María Sanchez-Palop, Justo Martínez-Colmenero, María Amparo Pimentel-Villar, Sara Blázquez-Roselló, José Juan Moreno-Sánchez, María López-Vílchez, Inmaculada Prior-Sánchez, Rosario Jódar-Moreno, Miguel Ángel López Ruz
Published 2021-01-01
Article